HealthQuill Cancer Markers
AbbVie Inc. and IGI Therapeutics SA have signed a $2 billion licensing agreement that gives AbbVie access to an antibody being tested for certain types of cancers and autoimmune conditions.
Drugs Health Pharma

AbbVie inks $2 billion deal with IGI, bags antibody to fight cancer 

HQ Team July 10, 2025: AbbVie Inc. and IGI Therapeutics SA have signed a $2 billion licensing agreement that gives AbbVie access to.

Read More